Work

Characterization of Tumor Size Changes Over Time from the Phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (Select)

Year: 2014

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu340.46

Authors: B. Robinson, M. Schlumberger, L.J. Wirth, C. Dutcus, B.D.L. Heras, J. Zhu, M.H. Taylor, S.-. Kim, M.K. Krzyzanowska, J. Capdevila, S. Sherman, M. Tahara

Institutions: The University of Sydney, Institut Gustave Roussy, Massachusetts General Hospital, Eisai (United States), Eisai (United Kingdom), Oregon Health & Science University, OHSU Knight Cancer Institute, Asan Medical Center, University of Ulsan, Princess Margaret Cancer Centre, Vall d'Hebron Hospital Universitari, The University of Texas MD Anderson Cancer Center, National Cancer Center Hospital East

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2184499705

FWCI: 0.535

Cites: 1

Cited by: 2

Related to: 10